Tobacco and Nicotine Products Regulation and Policy Conference

October 24–25, 2024   In-Person & Virtual Event

Overview

Join a diverse group of stakeholders—public health advocates, researchers, manufacturers, lawyers, consumer interest groups, entrepreneurs, governmental agencies, and others—for this two-day conference on effectively regulating the broad spectrum of tobacco and nicotine products in the United States. Attendees will hear directly from FDA about the latest updates on regulations, guidance documents, and other initiatives. The conference will also include numerous discussions of timely tobacco and nicotine product issues and feature interactive dialogues between the panelists and audience.

Call for Proposals

Call for Proposals – BE CREATIVE!

FDLI invites you to submit a proposal for a session for the Tobacco and Nicotine Product Regulation and Policy Conference. Your submissions and input are integral to ensuring that the most timely and pertinent topics are covered at the conference. Topics should address issues relating to marketing, labeling, compliance, enforcement, and litigation as it impacts tobacco and nicotine products regulation and policy in the United States.

Proposal Submission Guidelines

  • Topics should be at an advanced level.
  • Topics that include a variety of perspectives and viewpoints, including government, industry, private attorneys, academics, and public interest, are preferred.
  • FDLI is committed to supporting, promoting, and celebrating diversity and inclusion in the food and drug law community. To that end, proposals addressing systematic or historical impacts on health care disparity and racial equity in relation to all areas of the FDA-regulated community are strongly encouraged.
  • We prefer submissions to include a reasonably detailed and thoughtful title for and description of the proposed session.

Submissions FAQ

  • Q: Am I limited in the number of proposals I can submit?
    • A: Multiple submissions from the same person or organization are welcome—however, each proposal requires its own form.
  • Q: How will my submission be reviewed?
    • A: All submissions are blinded before being reviewed by the Conference Planning Committee. All submissions are treated as recommendations, and proposals may be modified or combined by FDLI to best suit the needs of the conference.
  • Q: Do all items in my proposal need to be in final form?
    • A: No—Your proposal does not need to be in final form. A proposal can and will likely be updated by the Committee to include the newest or most up-to-date information as relevant for the FDLI audience.
  • Should I reach out to speakers I suggest in advance of submitting my proposal?
    • A: Suggested speakers should not be invited in advance—sessions are often combined and we cannot guarantee that suggested speakers will be included.
  • Q: Can I email you my submission?
    • All submissions must be received through the submission portal.
  • Q: If my topic is selected, do I get to speak? Do I have to speak if my topic is selected?
    • A: Speaking opportunities are generally reserved for FDLI members. If your topic is selected, you will be invited to speak if you are interested; however, speaking is not a requirement to submit a topic.
  • Q: How will I know if my submission is accepted?
    • A: You will be notified of the status of your submission approximately three months before the conference date.

Proposal Submission Timeline

  • May 24: Call for Proposals closes.
  • Mid-July: Those who submitted proposals will be notified of their submission’s status.

Early registration expires 7/31/2024

$1499

Members

$1999

Non-Members

Industry

$1499

Members

$1999

Non-Members

Government
& Association

$999

Members

$1099

Non-Members

Public/Patient Org
& Academic

$899

Members

$999

Non-Members

Student

Free

Members

$999

Non-Members

Gold

Jasjit Ahluwhalia, Brown University
Maham Akbar, Truth Initiative
Aruni Bhatnagar, University of Louisville
Shelly Blackwell, EAS Consulting Group
Brittani Cushman, Turning Point Brands, Inc.
Clifford E. Douglas, Foundation for a Smoke-Free World
Connor Fuchs, Campaign for Tobacco-Free Kids
Joe G. Gitchell, Pinney Associates, Inc.
Bryan M. Haynes, Troutman Pepper Hamilton Sanders LLP
Eshael Johnson, FDA–CTP
Rima Khoury, Fumari, Inc.
Michelle Lynch, North American Quitline Consortium
John L. Marshall, Altria Client Services LLC
Daniel P. McGee, Keller and Heckman LLP
Brian J. Miller, Johns Hopkins University
Gaye Montgomery, Black Buffalo Inc.
John O’Brien, RAI Service Company (RAISC) (Reynolds American Inc.)
Elizabeth Oestreich, ELIQUENT Life Sciences
Henry Roemer, Finger, Roemer, Brown & Mariani LLP
Sharyn Rutt, Philip Morris International
Barry Schaevitz, Fox Rothschild LLP
Jim Solyst, JMS Scientific Engagement
Mark J. Vaders, Womble Bond Dickinson (US) LLP
Jeffrey Weiss, Flagstaff Ventures
Tanya Wells, Vermont Department of Health